Literature DB >> 18420144

Mitochondria-penetrating peptides.

Kristin L Horton1, Kelly M Stewart, Sonali B Fonseca, Qian Guo, Shana O Kelley.   

Abstract

Mitochondria are important targets for cancer chemotherapy and other disease treatments. Gaining access to this organelle can be difficult, as the inner membrane is a barrier limiting diffusive transport. A mitochondrial molecular carrier would be a boon to the development of organelle-specific therapeutics. Here, we report a significant advance in the development of mitochondrial transporters-synthetic cell-permeable peptides that are able to enter mitochondria. Efficient uptake of these mitochondria-penetrating peptides (MPPs) is observed in a variety of cell types, and organellar specificity is attained with sequences that possess specific chemical properties. The MPPs identified are cationic, but also lipophilic; this combination of characteristics facilitates permeation of the hydrophobic mitochondrial membrane. The examination of a panel of MPPs illustrates that mitochondrial localization can be rationally controlled and finely tuned by altering lipophilicity and charge.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420144     DOI: 10.1016/j.chembiol.2008.03.015

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  98 in total

1.  Multiple triphenylphosphonium cations as a platform for the delivery of a pro-apoptotic peptide.

Authors:  Netanel Kolevzon; Uriel Kuflik; Miriam Shmuel; Sandrine Benhamron; Israel Ringel; Eylon Yavin
Journal:  Pharm Res       Date:  2011-06-02       Impact factor: 4.200

2.  Targeting a ruthenium complex to the nucleus with short peptides.

Authors:  Cindy A Puckett; Jacqueline K Barton
Journal:  Bioorg Med Chem       Date:  2010-04-08       Impact factor: 3.641

3.  Cell-penetrating and mitochondrion-targeting molecules.

Authors:  George Appiah Kubi; Dehua Pei
Journal:  Methods Enzymol       Date:  2020-06-17       Impact factor: 1.600

Review 4.  Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.

Authors:  Gantumur Battogtokh; Yeon Su Choi; Dong Seop Kang; Sang Jun Park; Min Suk Shim; Kang Moo Huh; Yong-Yeon Cho; Joo Young Lee; Hye Suk Lee; Han Chang Kang
Journal:  Acta Pharm Sin B       Date:  2018-05-18       Impact factor: 11.413

Review 5.  Mitochondria as a target in treatment.

Authors:  Marie-Céline Frantz; Peter Wipf
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

6.  Dimeric cationic amphiphilic polyproline helices for mitochondrial targeting.

Authors:  Iris M Geisler; Jean Chmielewski
Journal:  Pharm Res       Date:  2011-06-07       Impact factor: 4.200

Review 7.  Novel therapies targeting inner mitochondrial membrane--from discovery to clinical development.

Authors:  Hazel H Szeto; Peter W Schiller
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

8.  Development of novel peptides for mitochondrial drug delivery: amino acids featuring delocalized lipophilic cations.

Authors:  Shana O Kelley; Kelly M Stewart; Rida Mourtada
Journal:  Pharm Res       Date:  2011-08-11       Impact factor: 4.200

9.  Evaluation of 64Cu-labeled acridinium cation: a PET radiotracer targeting tumor mitochondria.

Authors:  Yang Zhou; Young-Seung Kim; Jiyun Shi; Orit Jacobson; Xiaoyuan Chen; Shuang Liu
Journal:  Bioconjug Chem       Date:  2011-03-17       Impact factor: 4.774

Review 10.  Targeting mitochondria in cancer: current concepts and immunotherapy approaches.

Authors:  Sergey Pustylnikov; Francesca Costabile; Silvia Beghi; Andrea Facciabene
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.